Psychedelics as potential mental health treatment are explored by Trump administration
The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared.
«The Department shares the goal of ensuring that all Americans — especially our nation’s veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression,» a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital.
«Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges.»
FDA APPROVES FIRST AI TOOL TO PREDICT BREAST CANCER RISK
In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin («magic mushrooms») to treat mental health disorders.
MDMA is not approved for clinical use by the U.S. Food and Drug Admi..